Therefore, Bmi-1 also is an oncogene, and its abnormal expression is associated with tumorigenesis and drug resistance in many cancers, including bladder cancer cells, B-cell lymphoma cells, melanoma cells, and others. The gene discussed is BMI1; the disease is urinary bladder carcinoma.